Emyria (ASX:EMD) Debt-to-Revenue : 1.36 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Emyria Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Emyria's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$2.22 Mil. Emyria's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.75 Mil. Emyria's annualized Revenue for the quarter that ended in Dec. 2023 was A$2.18 Mil. Emyria's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 1.36.

Emyria Debt-to-Revenue Historical Data

The historical data trend for Emyria's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emyria Debt-to-Revenue Chart

Emyria Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Revenue

N/A

0.60

0.79

0.47

0.80

Emyria Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial			0.42	0.56	0.89	0.74	1.36

Competitive Comparison of Emyria's Debt-to-Revenue

For the Health Information Services subindustry, Emyria's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emyria's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Emyria's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Emyria's Debt-to-Revenue falls into.

Emyria Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Emyria's Debt-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(1.131	+	0.14)	/	1.592
	=	0.80

Emyria's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(2.216	+	0.748)	/	2.18
	=	1.36

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.

Emyria Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Emyria's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Emyria (ASX:EMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Emyria Ltd (ASX:EMD) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

D2 661 Newcastle Street, PO Box 1442, Leederville, WA, AUS, 6007

Website

https://www.emeraldclinics.com.au

Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.